nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—ABCB1—schizophrenia	0.0397	1	CbGaD
Sunitinib—Metoclopramide—HTR3A—schizophrenia	0.00282	0.244	CrCbGaD
Sunitinib—Procainamide—DNMT1—schizophrenia	0.00261	0.227	CrCbGaD
Sunitinib—Metoclopramide—CHRM1—schizophrenia	0.0021	0.182	CrCbGaD
Sunitinib—Metoclopramide—DRD3—schizophrenia	0.00161	0.139	CrCbGaD
Sunitinib—Metoclopramide—DRD2—schizophrenia	0.00111	0.0964	CrCbGaD
Sunitinib—Metoclopramide—CYP2D6—schizophrenia	0.000786	0.0681	CrCbGaD
Sunitinib—Procainamide—CYP2D6—schizophrenia	0.000499	0.0433	CrCbGaD
Sunitinib—PTK2B—nervous system—schizophrenia	0.000317	0.000787	CbGeAlD
Sunitinib—CSNK1A1—cerebellum—schizophrenia	0.000317	0.000787	CbGeAlD
Sunitinib—FYN—midbrain—schizophrenia	0.000317	0.000786	CbGeAlD
Sunitinib—CAMK2G—central nervous system—schizophrenia	0.000316	0.000785	CbGeAlD
Sunitinib—BMP2K—central nervous system—schizophrenia	0.000316	0.000785	CbGeAlD
Sunitinib—CYP3A5—blood plasma—schizophrenia	0.000316	0.000784	CbGeAlD
Sunitinib—CLK1—cerebellum—schizophrenia	0.000315	0.000781	CbGeAlD
Sunitinib—STK16—brain—schizophrenia	0.000315	0.000781	CbGeAlD
Sunitinib—LRRK2—central nervous system—schizophrenia	0.000313	0.000778	CbGeAlD
Sunitinib—MAP4K5—blood—schizophrenia	0.000313	0.000778	CbGeAlD
Sunitinib—MAP3K3—blood—schizophrenia	0.000313	0.000778	CbGeAlD
Sunitinib—HIPK2—brain—schizophrenia	0.000313	0.000777	CbGeAlD
Sunitinib—HIPK3—brain—schizophrenia	0.000313	0.000777	CbGeAlD
Sunitinib—TYRO3—brain—schizophrenia	0.000313	0.000777	CbGeAlD
Sunitinib—ALK—brain—schizophrenia	0.000313	0.000777	CbGeAlD
Sunitinib—KIT—telencephalon—schizophrenia	0.000312	0.000775	CbGeAlD
Sunitinib—CSNK1E—nervous system—schizophrenia	0.000312	0.000775	CbGeAlD
Sunitinib—TBK1—endocrine gland—schizophrenia	0.000312	0.000774	CbGeAlD
Sunitinib—TYK2—endocrine gland—schizophrenia	0.00031	0.000769	CbGeAlD
Sunitinib—TNK1—brain—schizophrenia	0.00031	0.000769	CbGeAlD
Sunitinib—RIOK2—brain—schizophrenia	0.00031	0.000769	CbGeAlD
Sunitinib—MAP4K5—midbrain—schizophrenia	0.000309	0.000768	CbGeAlD
Sunitinib—MAP3K3—midbrain—schizophrenia	0.000309	0.000768	CbGeAlD
Sunitinib—CAMK2G—cerebellum—schizophrenia	0.000309	0.000767	CbGeAlD
Sunitinib—BMP2K—cerebellum—schizophrenia	0.000309	0.000767	CbGeAlD
Sunitinib—PRKAA1—central nervous system—schizophrenia	0.000309	0.000767	CbGeAlD
Sunitinib—IRAK4—nervous system—schizophrenia	0.000307	0.000762	CbGeAlD
Sunitinib—MAP3K19—brain—schizophrenia	0.000307	0.000761	CbGeAlD
Sunitinib—MAP4K1—brain—schizophrenia	0.000307	0.000761	CbGeAlD
Sunitinib—LRRK2—cerebellum—schizophrenia	0.000306	0.00076	CbGeAlD
Sunitinib—PTK2B—central nervous system—schizophrenia	0.000305	0.000758	CbGeAlD
Sunitinib—PDGFRB—telencephalon—schizophrenia	0.000305	0.000757	CbGeAlD
Sunitinib—FLT1—blood—schizophrenia	0.000303	0.000752	CbGeAlD
Sunitinib—PRKAA1—cerebellum—schizophrenia	0.000302	0.000749	CbGeAlD
Sunitinib—DAPK3—brain—schizophrenia	0.000301	0.000747	CbGeAlD
Sunitinib—CSNK1E—central nervous system—schizophrenia	0.0003	0.000746	CbGeAlD
Sunitinib—MAP2K2—nervous system—schizophrenia	0.0003	0.000746	CbGeAlD
Sunitinib—ULK3—nervous system—schizophrenia	0.0003	0.000746	CbGeAlD
Sunitinib—RPS6KB1—endocrine gland—schizophrenia	0.0003	0.000745	CbGeAlD
Sunitinib—EPHB6—blood—schizophrenia	0.000299	0.000743	CbGeAlD
Sunitinib—FLT1—midbrain—schizophrenia	0.000299	0.000743	CbGeAlD
Sunitinib—PTK2B—cerebellum—schizophrenia	0.000298	0.000741	CbGeAlD
Sunitinib—RET—endocrine gland—schizophrenia	0.000298	0.000741	CbGeAlD
Sunitinib—FGR—endocrine gland—schizophrenia	0.000298	0.000741	CbGeAlD
Sunitinib—MAP3K2—nervous system—schizophrenia	0.000298	0.00074	CbGeAlD
Sunitinib—CLK2—brain—schizophrenia	0.000298	0.00074	CbGeAlD
Sunitinib—AXL—endocrine gland—schizophrenia	0.000297	0.000738	CbGeAlD
Sunitinib—MAP4K2—brain—schizophrenia	0.000296	0.000736	CbGeAlD
Sunitinib—IRAK4—central nervous system—schizophrenia	0.000296	0.000734	CbGeAlD
Sunitinib—EPHB6—midbrain—schizophrenia	0.000296	0.000734	CbGeAlD
Sunitinib—CSNK1E—cerebellum—schizophrenia	0.000294	0.000729	CbGeAlD
Sunitinib—FGFR1—cerebellum—schizophrenia	0.000294	0.000729	CbGeAlD
Sunitinib—STK3—brain—schizophrenia	0.000293	0.000726	CbGeAlD
Sunitinib—TBK1—nervous system—schizophrenia	0.000292	0.000725	CbGeAlD
Sunitinib—TYK2—nervous system—schizophrenia	0.00029	0.00072	CbGeAlD
Sunitinib—YES1—blood—schizophrenia	0.000289	0.000718	CbGeAlD
Sunitinib—ULK3—central nervous system—schizophrenia	0.000289	0.000718	CbGeAlD
Sunitinib—MAP2K2—central nervous system—schizophrenia	0.000289	0.000718	CbGeAlD
Sunitinib—IRAK4—cerebellum—schizophrenia	0.000289	0.000717	CbGeAlD
Sunitinib—ROCK1—brain—schizophrenia	0.000289	0.000717	CbGeAlD
Sunitinib—MAP3K2—central nervous system—schizophrenia	0.000287	0.000713	CbGeAlD
Sunitinib—CSF1R—gonad—schizophrenia	0.000287	0.000712	CbGeAlD
Sunitinib—STK10—blood—schizophrenia	0.000287	0.000712	CbGeAlD
Sunitinib—YES1—midbrain—schizophrenia	0.000286	0.000709	CbGeAlD
Sunitinib—TAOK3—blood—schizophrenia	0.000286	0.000709	CbGeAlD
Sunitinib—CYP3A7—endocrine gland—schizophrenia	0.000285	0.000707	CbGeAlD
Sunitinib—PDGFRA—blood—schizophrenia	0.000284	0.000705	CbGeAlD
Sunitinib—FGFR2—endocrine gland—schizophrenia	0.000283	0.000704	CbGeAlD
Sunitinib—MAP2K2—cerebellum—schizophrenia	0.000283	0.000702	CbGeAlD
Sunitinib—ULK3—cerebellum—schizophrenia	0.000283	0.000702	CbGeAlD
Sunitinib—TAOK3—midbrain—schizophrenia	0.000282	0.0007	CbGeAlD
Sunitinib—JAK2—endocrine gland—schizophrenia	0.000282	0.0007	CbGeAlD
Sunitinib—DYRK1A—brain—schizophrenia	0.000282	0.000699	CbGeAlD
Sunitinib—TBK1—central nervous system—schizophrenia	0.000281	0.000698	CbGeAlD
Sunitinib—RPS6KB1—nervous system—schizophrenia	0.000281	0.000697	CbGeAlD
Sunitinib—MAP3K2—cerebellum—schizophrenia	0.000281	0.000697	CbGeAlD
Sunitinib—TYK2—central nervous system—schizophrenia	0.000279	0.000693	CbGeAlD
Sunitinib—FGR—nervous system—schizophrenia	0.000279	0.000693	CbGeAlD
Sunitinib—RET—nervous system—schizophrenia	0.000279	0.000693	CbGeAlD
Sunitinib—AXL—nervous system—schizophrenia	0.000278	0.00069	CbGeAlD
Sunitinib—FYN—endocrine gland—schizophrenia	0.000278	0.00069	CbGeAlD
Sunitinib—MAP3K7—cerebellum—schizophrenia	0.000278	0.00069	CbGeAlD
Sunitinib—MERTK—brain—schizophrenia	0.000275	0.000683	CbGeAlD
Sunitinib—TBK1—cerebellum—schizophrenia	0.000275	0.000682	CbGeAlD
Sunitinib—TYK2—cerebellum—schizophrenia	0.000273	0.000678	CbGeAlD
Sunitinib—MAP4K5—endocrine gland—schizophrenia	0.000272	0.000675	CbGeAlD
Sunitinib—MAP3K3—endocrine gland—schizophrenia	0.000272	0.000675	CbGeAlD
Sunitinib—RPS6KB1—central nervous system—schizophrenia	0.00027	0.000671	CbGeAlD
Sunitinib—MAP4K4—brain—schizophrenia	0.00027	0.00067	CbGeAlD
Sunitinib—IRAK1—cerebellum—schizophrenia	0.000269	0.000669	CbGeAlD
Sunitinib—FGR—central nervous system—schizophrenia	0.000269	0.000667	CbGeAlD
Sunitinib—RET—central nervous system—schizophrenia	0.000269	0.000667	CbGeAlD
Sunitinib—NUAK2—brain—schizophrenia	0.000268	0.000665	CbGeAlD
Sunitinib—AXL—central nervous system—schizophrenia	0.000268	0.000665	CbGeAlD
Sunitinib—MAP3K12—brain—schizophrenia	0.000266	0.000661	CbGeAlD
Sunitinib—FGFR2—nervous system—schizophrenia	0.000265	0.000659	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—schizophrenia	0.000264	0.000656	CbGeAlD
Sunitinib—ABCC4—forebrain—schizophrenia	0.000264	0.000655	CbGeAlD
Sunitinib—JAK2—nervous system—schizophrenia	0.000264	0.000655	CbGeAlD
Sunitinib—RET—cerebellum—schizophrenia	0.000263	0.000652	CbGeAlD
Sunitinib—FLT1—endocrine gland—schizophrenia	0.000263	0.000652	CbGeAlD
Sunitinib—RPS6KA3—brain—schizophrenia	0.000262	0.000652	CbGeAlD
Sunitinib—AXL—cerebellum—schizophrenia	0.000262	0.00065	CbGeAlD
Sunitinib—MAP2K1—brain—schizophrenia	0.000261	0.000647	CbGeAlD
Sunitinib—KIT—gonad—schizophrenia	0.00026	0.000646	CbGeAlD
Sunitinib—FYN—nervous system—schizophrenia	0.00026	0.000646	CbGeAlD
Sunitinib—CSNK1A1—brain—schizophrenia	0.000257	0.000639	CbGeAlD
Sunitinib—KDR—blood—schizophrenia	0.000256	0.000636	CbGeAlD
Sunitinib—MAP2K5—blood—schizophrenia	0.000256	0.000636	CbGeAlD
Sunitinib—CLK1—brain—schizophrenia	0.000256	0.000635	CbGeAlD
Sunitinib—FGFR2—central nervous system—schizophrenia	0.000255	0.000634	CbGeAlD
Sunitinib—PDGFRB—gonad—schizophrenia	0.000254	0.000631	CbGeAlD
Sunitinib—MAP3K3—nervous system—schizophrenia	0.000254	0.000631	CbGeAlD
Sunitinib—MAP4K5—nervous system—schizophrenia	0.000254	0.000631	CbGeAlD
Sunitinib—JAK2—central nervous system—schizophrenia	0.000254	0.000631	CbGeAlD
Sunitinib—MAP2K5—midbrain—schizophrenia	0.000253	0.000628	CbGeAlD
Sunitinib—KDR—midbrain—schizophrenia	0.000253	0.000628	CbGeAlD
Sunitinib—SLK—cerebellum—schizophrenia	0.000252	0.000625	CbGeAlD
Sunitinib—BMP2K—brain—schizophrenia	0.000251	0.000623	CbGeAlD
Sunitinib—CAMK2G—brain—schizophrenia	0.000251	0.000623	CbGeAlD
Sunitinib—YES1—endocrine gland—schizophrenia	0.000251	0.000623	CbGeAlD
Sunitinib—FYN—central nervous system—schizophrenia	0.000251	0.000622	CbGeAlD
Sunitinib—CSF1R—blood—schizophrenia	0.00025	0.00062	CbGeAlD
Sunitinib—FGFR2—cerebellum—schizophrenia	0.00025	0.00062	CbGeAlD
Sunitinib—LRRK2—brain—schizophrenia	0.000249	0.000617	CbGeAlD
Sunitinib—STK10—endocrine gland—schizophrenia	0.000249	0.000617	CbGeAlD
Sunitinib—JAK2—cerebellum—schizophrenia	0.000248	0.000616	CbGeAlD
Sunitinib—TAOK3—endocrine gland—schizophrenia	0.000248	0.000615	CbGeAlD
Sunitinib—CSF1R—midbrain—schizophrenia	0.000247	0.000613	CbGeAlD
Sunitinib—PDGFRA—endocrine gland—schizophrenia	0.000246	0.000611	CbGeAlD
Sunitinib—FLT1—nervous system—schizophrenia	0.000246	0.00061	CbGeAlD
Sunitinib—PRKAA1—brain—schizophrenia	0.000245	0.000609	CbGeAlD
Sunitinib—FYN—cerebellum—schizophrenia	0.000245	0.000608	CbGeAlD
Sunitinib—MAP3K3—central nervous system—schizophrenia	0.000245	0.000608	CbGeAlD
Sunitinib—MAP4K5—central nervous system—schizophrenia	0.000245	0.000608	CbGeAlD
Sunitinib—EPHB6—nervous system—schizophrenia	0.000243	0.000603	CbGeAlD
Sunitinib—PTK2B—brain—schizophrenia	0.000242	0.000602	CbGeAlD
Sunitinib—FLT4—brain—schizophrenia	0.000242	0.0006	CbGeAlD
Sunitinib—MAP4K5—cerebellum—schizophrenia	0.000239	0.000594	CbGeAlD
Sunitinib—MAP3K3—cerebellum—schizophrenia	0.000239	0.000594	CbGeAlD
Sunitinib—CSNK1E—brain—schizophrenia	0.000238	0.000592	CbGeAlD
Sunitinib—FGFR1—brain—schizophrenia	0.000238	0.000592	CbGeAlD
Sunitinib—CYP3A4—blood plasma—schizophrenia	0.000237	0.000588	CbGeAlD
Sunitinib—FLT1—central nervous system—schizophrenia	0.000237	0.000588	CbGeAlD
Sunitinib—YES1—nervous system—schizophrenia	0.000235	0.000583	CbGeAlD
Sunitinib—IRAK4—brain—schizophrenia	0.000235	0.000583	CbGeAlD
Sunitinib—EPHB6—central nervous system—schizophrenia	0.000234	0.000581	CbGeAlD
Sunitinib—STK10—nervous system—schizophrenia	0.000233	0.000578	CbGeAlD
Sunitinib—TAOK3—nervous system—schizophrenia	0.000232	0.000576	CbGeAlD
Sunitinib—FLT1—cerebellum—schizophrenia	0.000231	0.000574	CbGeAlD
Sunitinib—PDGFRA—nervous system—schizophrenia	0.00023	0.000572	CbGeAlD
Sunitinib—ULK3—brain—schizophrenia	0.00023	0.00057	CbGeAlD
Sunitinib—MAP2K2—brain—schizophrenia	0.00023	0.00057	CbGeAlD
Sunitinib—EPHB6—cerebellum—schizophrenia	0.000229	0.000568	CbGeAlD
Sunitinib—MAP3K2—brain—schizophrenia	0.000228	0.000566	CbGeAlD
Sunitinib—KIT—blood—schizophrenia	0.000227	0.000563	CbGeAlD
Sunitinib—YES1—central nervous system—schizophrenia	0.000226	0.000561	CbGeAlD
Sunitinib—MAP3K7—brain—schizophrenia	0.000226	0.00056	CbGeAlD
Sunitinib—STK10—central nervous system—schizophrenia	0.000224	0.000556	CbGeAlD
Sunitinib—KIT—midbrain—schizophrenia	0.000224	0.000556	CbGeAlD
Sunitinib—TAOK3—central nervous system—schizophrenia	0.000223	0.000554	CbGeAlD
Sunitinib—TBK1—brain—schizophrenia	0.000223	0.000554	CbGeAlD
Sunitinib—KDR—endocrine gland—schizophrenia	0.000222	0.000551	CbGeAlD
Sunitinib—MAP2K5—endocrine gland—schizophrenia	0.000222	0.000551	CbGeAlD
Sunitinib—PDGFRA—central nervous system—schizophrenia	0.000222	0.000551	CbGeAlD
Sunitinib—TYK2—brain—schizophrenia	0.000222	0.00055	CbGeAlD
Sunitinib—PDGFRB—blood—schizophrenia	0.000222	0.00055	CbGeAlD
Sunitinib—YES1—cerebellum—schizophrenia	0.000221	0.000549	CbGeAlD
Sunitinib—STK10—cerebellum—schizophrenia	0.000219	0.000544	CbGeAlD
Sunitinib—PDGFRB—midbrain—schizophrenia	0.000219	0.000543	CbGeAlD
Sunitinib—IRAK1—brain—schizophrenia	0.000219	0.000543	CbGeAlD
Sunitinib—TAOK3—cerebellum—schizophrenia	0.000218	0.000542	CbGeAlD
Sunitinib—PDGFRA—cerebellum—schizophrenia	0.000217	0.000538	CbGeAlD
Sunitinib—CSF1R—endocrine gland—schizophrenia	0.000217	0.000538	CbGeAlD
Sunitinib—RPS6KB1—brain—schizophrenia	0.000215	0.000533	CbGeAlD
Sunitinib—RET—brain—schizophrenia	0.000213	0.00053	CbGeAlD
Sunitinib—FGR—brain—schizophrenia	0.000213	0.00053	CbGeAlD
Sunitinib—AXL—brain—schizophrenia	0.000213	0.000528	CbGeAlD
Sunitinib—KCNH2—forebrain—schizophrenia	0.000209	0.00052	CbGeAlD
Sunitinib—KDR—nervous system—schizophrenia	0.000208	0.000516	CbGeAlD
Sunitinib—MAP2K5—nervous system—schizophrenia	0.000208	0.000516	CbGeAlD
Sunitinib—SLK—brain—schizophrenia	0.000205	0.000508	CbGeAlD
Sunitinib—CSF1R—nervous system—schizophrenia	0.000203	0.000504	CbGeAlD
Sunitinib—FGFR2—brain—schizophrenia	0.000203	0.000503	CbGeAlD
Sunitinib—JAK2—brain—schizophrenia	0.000202	0.000501	CbGeAlD
Sunitinib—KDR—central nervous system—schizophrenia	0.0002	0.000497	CbGeAlD
Sunitinib—MAP2K5—central nervous system—schizophrenia	0.0002	0.000497	CbGeAlD
Sunitinib—FYN—brain—schizophrenia	0.000199	0.000494	CbGeAlD
Sunitinib—KIT—endocrine gland—schizophrenia	0.000197	0.000489	CbGeAlD
Sunitinib—KDR—cerebellum—schizophrenia	0.000196	0.000486	CbGeAlD
Sunitinib—MAP2K5—cerebellum—schizophrenia	0.000196	0.000486	CbGeAlD
Sunitinib—CSF1R—central nervous system—schizophrenia	0.000195	0.000485	CbGeAlD
Sunitinib—MAP3K3—brain—schizophrenia	0.000194	0.000483	CbGeAlD
Sunitinib—MAP4K5—brain—schizophrenia	0.000194	0.000483	CbGeAlD
Sunitinib—KCNH2—telencephalon—schizophrenia	0.000193	0.000478	CbGeAlD
Sunitinib—PDGFRB—endocrine gland—schizophrenia	0.000192	0.000477	CbGeAlD
Sunitinib—CSF1R—cerebellum—schizophrenia	0.000191	0.000474	CbGeAlD
Sunitinib—FLT1—brain—schizophrenia	0.000188	0.000467	CbGeAlD
Sunitinib—EPHB6—brain—schizophrenia	0.000186	0.000461	CbGeAlD
Sunitinib—KIT—nervous system—schizophrenia	0.000184	0.000457	CbGeAlD
Sunitinib—PDGFRB—nervous system—schizophrenia	0.00018	0.000447	CbGeAlD
Sunitinib—YES1—brain—schizophrenia	0.00018	0.000446	CbGeAlD
Sunitinib—STK10—brain—schizophrenia	0.000178	0.000442	CbGeAlD
Sunitinib—KIT—central nervous system—schizophrenia	0.000177	0.00044	CbGeAlD
Sunitinib—TAOK3—brain—schizophrenia	0.000177	0.00044	CbGeAlD
Sunitinib—ABCC4—blood—schizophrenia	0.000176	0.000438	CbGeAlD
Sunitinib—PDGFRA—brain—schizophrenia	0.000176	0.000437	CbGeAlD
Sunitinib—KIT—cerebellum—schizophrenia	0.000173	0.00043	CbGeAlD
Sunitinib—PDGFRB—central nervous system—schizophrenia	0.000173	0.00043	CbGeAlD
Sunitinib—ABCG2—telencephalon—schizophrenia	0.000171	0.000425	CbGeAlD
Sunitinib—ABCC2—blood—schizophrenia	0.000171	0.000424	CbGeAlD
Sunitinib—PDGFRB—cerebellum—schizophrenia	0.000169	0.00042	CbGeAlD
Sunitinib—ABCB1—blood plasma—schizophrenia	0.000168	0.000416	CbGeAlD
Sunitinib—KDR—brain—schizophrenia	0.000159	0.000394	CbGeAlD
Sunitinib—MAP2K5—brain—schizophrenia	0.000159	0.000394	CbGeAlD
Sunitinib—CSF1R—brain—schizophrenia	0.000155	0.000385	CbGeAlD
Sunitinib—ABCC4—endocrine gland—schizophrenia	0.000153	0.00038	CbGeAlD
Sunitinib—ABCC2—endocrine gland—schizophrenia	0.000148	0.000368	CbGeAlD
Sunitinib—ABCC4—nervous system—schizophrenia	0.000143	0.000356	CbGeAlD
Sunitinib—KIT—brain—schizophrenia	0.000141	0.00035	CbGeAlD
Sunitinib—KCNH2—blood—schizophrenia	0.00014	0.000348	CbGeAlD
Sunitinib—KCNH2—midbrain—schizophrenia	0.000138	0.000343	CbGeAlD
Sunitinib—ABCC4—central nervous system—schizophrenia	0.000138	0.000342	CbGeAlD
Sunitinib—PDGFRB—brain—schizophrenia	0.000138	0.000341	CbGeAlD
Sunitinib—ABCG2—blood—schizophrenia	0.000125	0.000309	CbGeAlD
Sunitinib—ABCG2—midbrain—schizophrenia	0.000123	0.000305	CbGeAlD
Sunitinib—KCNH2—endocrine gland—schizophrenia	0.000121	0.000301	CbGeAlD
Sunitinib—CYP3A5—blood—schizophrenia	0.000116	0.000287	CbGeAlD
Sunitinib—KCNH2—nervous system—schizophrenia	0.000114	0.000282	CbGeAlD
Sunitinib—ABCC4—brain—schizophrenia	0.000109	0.000272	CbGeAlD
Sunitinib—KCNH2—central nervous system—schizophrenia	0.000109	0.000272	CbGeAlD
Sunitinib—KCNH2—cerebellum—schizophrenia	0.000107	0.000266	CbGeAlD
Sunitinib—CYP3A5—endocrine gland—schizophrenia	0.0001	0.000249	CbGeAlD
Sunitinib—ABCG2—cerebellum—schizophrenia	9.51e-05	0.000236	CbGeAlD
Sunitinib—ABCB1—forebrain—schizophrenia	9.18e-05	0.000228	CbGeAlD
Sunitinib—KCNH2—brain—schizophrenia	8.69e-05	0.000216	CbGeAlD
Sunitinib—CYP3A4—blood—schizophrenia	8.68e-05	0.000215	CbGeAlD
Sunitinib—ABCB1—telencephalon—schizophrenia	8.45e-05	0.00021	CbGeAlD
Sunitinib—ABCG2—brain—schizophrenia	7.73e-05	0.000192	CbGeAlD
Sunitinib—CYP3A4—endocrine gland—schizophrenia	7.53e-05	0.000187	CbGeAlD
Sunitinib—ABCB1—gonad—schizophrenia	7.05e-05	0.000175	CbGeAlD
Sunitinib—CYP3A4—nervous system—schizophrenia	7.04e-05	0.000175	CbGeAlD
Sunitinib—CYP3A4—central nervous system—schizophrenia	6.78e-05	0.000168	CbGeAlD
Sunitinib—ABCB1—blood—schizophrenia	6.14e-05	0.000152	CbGeAlD
Sunitinib—ABCB1—midbrain—schizophrenia	6.06e-05	0.000151	CbGeAlD
Sunitinib—ABCB1—endocrine gland—schizophrenia	5.33e-05	0.000132	CbGeAlD
Sunitinib—ABCB1—nervous system—schizophrenia	4.99e-05	0.000124	CbGeAlD
Sunitinib—ABCB1—central nervous system—schizophrenia	4.8e-05	0.000119	CbGeAlD
Sunitinib—ABCB1—cerebellum—schizophrenia	4.69e-05	0.000116	CbGeAlD
Sunitinib—ABCB1—brain—schizophrenia	3.81e-05	9.46e-05	CbGeAlD
Sunitinib—FGFR2—Adaptive Immune System—AKT1—schizophrenia	2.66e-06	4.88e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—GSK3B—schizophrenia	2.66e-06	4.87e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—YWHAZ—schizophrenia	2.66e-06	4.87e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—TH—schizophrenia	2.64e-06	4.84e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—EP300—schizophrenia	2.64e-06	4.84e-06	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TP53—schizophrenia	2.64e-06	4.84e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HTR2A—schizophrenia	2.63e-06	4.82e-06	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—AKT1—schizophrenia	2.63e-06	4.81e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—GSK3B—schizophrenia	2.63e-06	4.81e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—EP300—schizophrenia	2.63e-06	4.81e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—EP300—schizophrenia	2.63e-06	4.81e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HTR2A—schizophrenia	2.62e-06	4.8e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—AKT1—schizophrenia	2.62e-06	4.79e-06	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—AKT1—schizophrenia	2.62e-06	4.79e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—APOE—schizophrenia	2.6e-06	4.77e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ERBB3—schizophrenia	2.6e-06	4.76e-06	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—AKT1—schizophrenia	2.58e-06	4.73e-06	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—AKT1—schizophrenia	2.58e-06	4.73e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—GSK3B—schizophrenia	2.58e-06	4.72e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—GSK3B—schizophrenia	2.58e-06	4.72e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—AKT1—schizophrenia	2.58e-06	4.72e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—APOA1—schizophrenia	2.57e-06	4.71e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL1B—schizophrenia	2.57e-06	4.7e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CACNA1C—schizophrenia	2.56e-06	4.69e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP26B1—schizophrenia	2.55e-06	4.68e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—APOE—schizophrenia	2.54e-06	4.65e-06	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—AKT1—schizophrenia	2.54e-06	4.65e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—MTHFR—schizophrenia	2.54e-06	4.65e-06	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—AKT1—schizophrenia	2.54e-06	4.64e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—AKT1—schizophrenia	2.52e-06	4.62e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TP53—schizophrenia	2.52e-06	4.61e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—MTHFR—schizophrenia	2.51e-06	4.61e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—APOA1—schizophrenia	2.51e-06	4.6e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL1B—schizophrenia	2.5e-06	4.59e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HTR2A—schizophrenia	2.5e-06	4.59e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—EP300—schizophrenia	2.5e-06	4.58e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3C2A—schizophrenia	2.5e-06	4.57e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—EP300—schizophrenia	2.49e-06	4.56e-06	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—AKT1—schizophrenia	2.49e-06	4.56e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—EP300—schizophrenia	2.49e-06	4.55e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—ESR1—schizophrenia	2.48e-06	4.55e-06	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—AKT1—schizophrenia	2.48e-06	4.55e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—AKT1—schizophrenia	2.48e-06	4.54e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—AKT1—schizophrenia	2.47e-06	4.52e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—EP300—schizophrenia	2.47e-06	4.52e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—AKT1—schizophrenia	2.45e-06	4.49e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—APOE—schizophrenia	2.45e-06	4.48e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—GSK3B—schizophrenia	2.45e-06	4.48e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—GSK3B—schizophrenia	2.44e-06	4.47e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—APOE—schizophrenia	2.44e-06	4.46e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—ESR1—schizophrenia	2.42e-06	4.44e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—EP300—schizophrenia	2.42e-06	4.44e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—EP300—schizophrenia	2.42e-06	4.43e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—APOA1—schizophrenia	2.42e-06	4.43e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL1B—schizophrenia	2.41e-06	4.42e-06	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—AKT1—schizophrenia	2.41e-06	4.41e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—APOA1—schizophrenia	2.41e-06	4.41e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL1B—schizophrenia	2.4e-06	4.4e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—AKT1—schizophrenia	2.39e-06	4.37e-06	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—AKT1—schizophrenia	2.38e-06	4.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—AKT1—schizophrenia	2.38e-06	4.36e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—schizophrenia	2.37e-06	4.35e-06	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.36e-06	4.33e-06	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—AKT1—schizophrenia	2.36e-06	4.33e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—APOE—schizophrenia	2.36e-06	4.33e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—schizophrenia	2.35e-06	4.31e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—APOE—schizophrenia	2.34e-06	4.29e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—ESR1—schizophrenia	2.34e-06	4.28e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—APOA1—schizophrenia	2.33e-06	4.28e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—EP300—schizophrenia	2.33e-06	4.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—APOE—schizophrenia	2.33e-06	4.26e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ESR1—schizophrenia	2.32e-06	4.26e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—AKT1—schizophrenia	2.32e-06	4.25e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—EP300—schizophrenia	2.32e-06	4.24e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—APOA1—schizophrenia	2.31e-06	4.24e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—APOA1—schizophrenia	2.3e-06	4.21e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—EP300—schizophrenia	2.3e-06	4.21e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1B—schizophrenia	2.29e-06	4.2e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—EP300—schizophrenia	2.29e-06	4.2e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—EP300—schizophrenia	2.29e-06	4.2e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TPH1—schizophrenia	2.28e-06	4.17e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCLM—schizophrenia	2.28e-06	4.17e-06	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—AKT1—schizophrenia	2.26e-06	4.14e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—GSK3B—schizophrenia	2.25e-06	4.13e-06	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—AKT1—schizophrenia	2.25e-06	4.13e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—COMT—schizophrenia	2.25e-06	4.12e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—EP300—schizophrenia	2.25e-06	4.11e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—EP300—schizophrenia	2.25e-06	4.11e-06	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—AKT1—schizophrenia	2.24e-06	4.1e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—EP300—schizophrenia	2.24e-06	4.1e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP2D6—schizophrenia	2.24e-06	4.1e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SNAP25—schizophrenia	2.24e-06	4.1e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GSTP1—schizophrenia	2.24e-06	4.1e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MAOA—schizophrenia	2.23e-06	4.09e-06	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—AKT1—schizophrenia	2.23e-06	4.09e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—AKT1—schizophrenia	2.23e-06	4.09e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—AKT1—schizophrenia	2.23e-06	4.08e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ESR1—schizophrenia	2.22e-06	4.07e-06	CbGpPWpGaD
Sunitinib—BLK—Immune System—AKT1—schizophrenia	2.21e-06	4.04e-06	CbGpPWpGaD
Sunitinib—FGR—Immune System—AKT1—schizophrenia	2.2e-06	4.03e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—GSK3B—schizophrenia	2.2e-06	4.03e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—EP300—schizophrenia	2.19e-06	4.01e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—EP300—schizophrenia	2.16e-06	3.95e-06	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—AKT1—schizophrenia	2.15e-06	3.94e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—EP300—schizophrenia	2.15e-06	3.93e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PRKD1—schizophrenia	2.14e-06	3.92e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—AKT1—schizophrenia	2.13e-06	3.9e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—AKT1—schizophrenia	2.13e-06	3.89e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—GSK3B—schizophrenia	2.12e-06	3.88e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ABCB1—schizophrenia	2.12e-06	3.88e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—EP300—schizophrenia	2.12e-06	3.88e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—GSK3B—schizophrenia	2.11e-06	3.86e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—EP300—schizophrenia	2.07e-06	3.79e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PLA2G4A—schizophrenia	2.06e-06	3.77e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GSTM1—schizophrenia	2.06e-06	3.77e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—EP300—schizophrenia	2.05e-06	3.76e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—schizophrenia	2.03e-06	3.72e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP1A2—schizophrenia	2.02e-06	3.71e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—GSK3B—schizophrenia	2.02e-06	3.69e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—AKT1—schizophrenia	2e-06	3.67e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TH—schizophrenia	2e-06	3.66e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—EP300—schizophrenia	1.99e-06	3.65e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—AKT1—schizophrenia	1.99e-06	3.64e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EP300—schizophrenia	1.98e-06	3.63e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—schizophrenia	1.91e-06	3.49e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EP300—schizophrenia	1.9e-06	3.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EP300—schizophrenia	1.89e-06	3.47e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—schizophrenia	1.89e-06	3.46e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MTHFR—schizophrenia	1.82e-06	3.33e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EP300—schizophrenia	1.8e-06	3.3e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—AKT1—schizophrenia	1.79e-06	3.28e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GAPDH—schizophrenia	1.79e-06	3.27e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—AKT1—schizophrenia	1.78e-06	3.25e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CLOCK—schizophrenia	1.77e-06	3.24e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EP300—schizophrenia	1.75e-06	3.21e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—schizophrenia	1.73e-06	3.17e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EP300—schizophrenia	1.73e-06	3.17e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CACNB2—schizophrenia	1.73e-06	3.16e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TPH2—schizophrenia	1.73e-06	3.16e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—AKT1—schizophrenia	1.72e-06	3.15e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—DPYD—schizophrenia	1.7e-06	3.11e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EP300—schizophrenia	1.7e-06	3.11e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EP300—schizophrenia	1.7e-06	3.11e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—COMT—schizophrenia	1.7e-06	3.11e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOE—schizophrenia	1.69e-06	3.1e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTP1—schizophrenia	1.69e-06	3.09e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—schizophrenia	1.68e-06	3.09e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MAOA—schizophrenia	1.68e-06	3.09e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOA1—schizophrenia	1.67e-06	3.06e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—schizophrenia	1.67e-06	3.06e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—schizophrenia	1.66e-06	3.04e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—schizophrenia	1.64e-06	3e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—schizophrenia	1.62e-06	2.96e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—schizophrenia	1.61e-06	2.95e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EP300—schizophrenia	1.61e-06	2.95e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—schizophrenia	1.61e-06	2.94e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—schizophrenia	1.61e-06	2.94e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EP300—schizophrenia	1.61e-06	2.94e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—schizophrenia	1.6e-06	2.92e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—schizophrenia	1.59e-06	2.91e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—schizophrenia	1.59e-06	2.91e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CACNA1C—schizophrenia	1.58e-06	2.89e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—schizophrenia	1.57e-06	2.87e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PLA2G4A—schizophrenia	1.55e-06	2.84e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—schizophrenia	1.55e-06	2.84e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	1.54e-06	2.82e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—schizophrenia	1.52e-06	2.78e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—schizophrenia	1.51e-06	2.77e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—schizophrenia	1.51e-06	2.76e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—schizophrenia	1.5e-06	2.75e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—schizophrenia	1.49e-06	2.74e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—schizophrenia	1.49e-06	2.73e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EP300—schizophrenia	1.48e-06	2.72e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—schizophrenia	1.46e-06	2.68e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—schizophrenia	1.46e-06	2.68e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EP300—schizophrenia	1.45e-06	2.65e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—schizophrenia	1.42e-06	2.6e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—schizophrenia	1.41e-06	2.58e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—schizophrenia	1.4e-06	2.56e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EP300—schizophrenia	1.4e-06	2.56e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—schizophrenia	1.39e-06	2.55e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EP300—schizophrenia	1.39e-06	2.54e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—schizophrenia	1.39e-06	2.54e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—schizophrenia	1.39e-06	2.54e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2D6—schizophrenia	1.38e-06	2.53e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SNAP25—schizophrenia	1.38e-06	2.53e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—schizophrenia	1.37e-06	2.51e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—schizophrenia	1.36e-06	2.49e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—schizophrenia	1.36e-06	2.49e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—schizophrenia	1.36e-06	2.49e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—schizophrenia	1.36e-06	2.49e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—schizophrenia	1.35e-06	2.48e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—EP300—schizophrenia	1.35e-06	2.47e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—EP300—schizophrenia	1.33e-06	2.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EP300—schizophrenia	1.33e-06	2.43e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—schizophrenia	1.32e-06	2.42e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—schizophrenia	1.3e-06	2.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—schizophrenia	1.3e-06	2.38e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—schizophrenia	1.29e-06	2.36e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—schizophrenia	1.28e-06	2.34e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—schizophrenia	1.28e-06	2.34e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOA1—schizophrenia	1.26e-06	2.31e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—schizophrenia	1.25e-06	2.29e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—schizophrenia	1.25e-06	2.29e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1A2—schizophrenia	1.25e-06	2.28e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—schizophrenia	1.24e-06	2.27e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—schizophrenia	1.24e-06	2.27e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TH—schizophrenia	1.23e-06	2.25e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—schizophrenia	1.21e-06	2.22e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—schizophrenia	1.21e-06	2.22e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—schizophrenia	1.2e-06	2.21e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—schizophrenia	1.2e-06	2.19e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—schizophrenia	1.15e-06	2.11e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—schizophrenia	1.15e-06	2.11e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—schizophrenia	1.15e-06	2.1e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—schizophrenia	1.14e-06	2.1e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—schizophrenia	1.09e-06	2e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—schizophrenia	1.06e-06	1.94e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—schizophrenia	1.06e-06	1.94e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—COMT—schizophrenia	1.05e-06	1.91e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—schizophrenia	1.04e-06	1.91e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—schizophrenia	1.04e-06	1.91e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MAOA—schizophrenia	1.04e-06	1.9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—schizophrenia	1.04e-06	1.9e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—schizophrenia	1.03e-06	1.88e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—schizophrenia	1.03e-06	1.88e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—schizophrenia	9.98e-07	1.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—schizophrenia	9.93e-07	1.82e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCB1—schizophrenia	9.85e-07	1.8e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—schizophrenia	9.73e-07	1.78e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—schizophrenia	9.71e-07	1.78e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—EP300—schizophrenia	9.64e-07	1.77e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	9.56e-07	1.75e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—schizophrenia	9.56e-07	1.75e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—schizophrenia	9.49e-07	1.74e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—schizophrenia	8.96e-07	1.64e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—schizophrenia	8.75e-07	1.6e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—schizophrenia	8.45e-07	1.55e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—schizophrenia	8.43e-07	1.54e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—schizophrenia	8.39e-07	1.54e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—schizophrenia	8.13e-07	1.49e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—schizophrenia	8.06e-07	1.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—schizophrenia	8.01e-07	1.47e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—schizophrenia	7.87e-07	1.44e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOA1—schizophrenia	7.78e-07	1.42e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—EP300—schizophrenia	7.28e-07	1.33e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—schizophrenia	5.83e-07	1.07e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—EP300—schizophrenia	4.48e-07	8.21e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—schizophrenia	4.4e-07	8.05e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—schizophrenia	2.71e-07	4.96e-07	CbGpPWpGaD
